Careers
Contact Us
Facebook
Twitter
LinkedIn
Home
About
Mission
Leaders
Science
Pipeline
Pz-cel
Manufacturing
The AIM
TM
Vector
Clinical Trials
Overview
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Patients & Families
Our Focus
Resources
Our Inspiration
Access Policy
Patient Advocacy & Community Engagement (PACE)
Investors & Media
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Careers
Contact Us
×
Home
About
Mission
Leaders
Science
Pipeline
Pz-cel
Manufacturing
The AIM
TM
Vector
Clinical Trials
Overview
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Patients & Families
Our Focus
Resources
Our Inspiration
Access Policy
Patient Advocacy & Community Engagement (PACE)
Investors & Media
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Careers
Contact Us
All SEC Filings
Investors
Investors & Media
Overview
News / Events
Overview
Press Releases
Events
Email Alerts
Company Info
Overview
Profile
Presentations
Management Team
Scientific Advisory Board
Contacts
Financial Info
Overview
Financial Results
Stock Data
Overview
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
144
25-NSE
3
4
4/A
424B1
424B3
424B4
424B5
425
8-A12B
8-A12G
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFR14A
DEFS14A
EFFECT
NO ACT
NT 10-K
NT 10-Q
NTN 10Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRES14A
PX14A6G
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-3DPOS
S-3MEF
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Date
Form
Description
PDF
XBRL
Pages
03/19/24
DEF 14A
Definitive proxy statements
35
03/18/24
8-K
Current report filing
Documents
EX-99.1
5
03/18/24
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-14
EX-19
EX-21
EX-23.1
EX-23.2
EX-31.1
EX-31.2
EX-32
EX-97.DESCRIPTION
74
03/15/24
4
Statement of changes in beneficial ownership of securities
1
03/12/24
4
Statement of changes in beneficial ownership of securities
1
02/14/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
02/14/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
02/14/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
02/14/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
02/12/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
2
3
4
5
6
7
8
9
10
11